c hicago gyn oncology updates

6
FRIDAY, MAY 14, 2021 INAUGURAL MEETING: VIRTUAL FORMAT COURSE DIRECTORS GINI FLEMING, MD | UNIVERSITY OF CHICAGO MEDICINE DIANE YAMADA, MD | UNIVERSITY OF CHICAGO MEDICINE KATHERINE KURNIT, MD, MPH | UNIVERSITY OF CHICAGO MEDICINE CHICAGO GYN ONCOLOGY UPDATES

Upload: others

Post on 01-Oct-2021

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: C HICAGO GYN ONCOLOGY UPDATES

FRIDAY, MAY 14, 2021INAUGURAL MEETING: VIRTUAL FORMAT

COURSE DIRECTORSGINI FLEMING, MD | UNIVERSITY OF CHICAGO MEDICINEDIANE YAMADA, MD | UNIVERSITY OF CHICAGO MEDICINEKATHERINE KURNIT, MD, MPH | UNIVERSITY OF CHICAGO MEDICINE

C H I C A G OGYN ONCOLOGY

U P D A T E S

Page 2: C HICAGO GYN ONCOLOGY UPDATES

LEARNING OBJECTIVESAt the conclusion of this activity, participants will be able to:

·· Define the mechanisms of action and side effect profiles of new gynecologic cancer therapies;

·· Discuss how to apply recent PARP inhibitor research to front-line therapy of ovarian cancer;

·· Describe how to select ovarian cancer patients for maintenance therapy with PARP inhibitors and for antiangiogenic therapy;

·· Identify strategies to explain to patients the efficacy results of immunotherapy and immunotherapy/antiangiogenic combination therapy in endometrial cancer;

·· Determine the sequencing and combination of new agents used for gynecologic cancer care with current therapies;

·· Identify contextual barriers to the integration of new gynecologic cancer agents into patient care;

·· Recall how to overcome barriers to recruit underserved populations for clinical trials;

·· Select appropriate tumor genomic tests for gynecologic cancer patients.

TARGET AUDIENCEThis activity is designed for gynecologic oncologists, medical oncologists, radiation oncologists, gynecologists, trainees, research scientists, nurses, nurse practitioners, physician assistants, and other healthcare professionals dedicated to the care of patients with gynecologic malignancies.

PHYSICIAN CREDITThe University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide

continuing medical education for physicians.

The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSING CREDITUniversity of Chicago Medicine is approved as a provider of nursing continuing professional development by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91)

This live activity is designated for a maximum of 3.25 continuing nursing education units.

AMERICAN BOARD OF INTERNAL MEDICINE MOC PART II CREDITSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

OTHER HEALTHCARE PROFESSIONALS CREDITOther healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.

COURSE DESCRIPTION

Chicago GYN Oncology Updates will celebrate contributions of SGO members, providing

access to the most important educational and scientific updates for women’s healthcare

professionals from the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s

Cancer. This conference will include information and resources for members of the entire

gynecologic cancer care team who provide treatment and care in the areas of chemotherapy,

radiation therapy, and surgery. This highly interactive program will provide participants with

distillations of advances in the fields of ovarian cancer and endometrial cancer. Topics will

include both appropriate use of new therapies including immunotherapy, antiangiogenic

agents, and PARP inhibitors, as well as information on appropriate use and applications of

genomic testing. In addition, the critical importance of clinical research will be highlighted

with presentations of Chicago area investigator-initiated trials and information regarding the

importance of and suggestions for inclusion of underserved populations in clinical research.

INFORMATION

Page 3: C HICAGO GYN ONCOLOGY UPDATES

FACULTY

COURSE DIRECTORSGini Fleming, MD Professor of Medicine

Medical Oncology Director,

Gynecologic Oncology

University of Chicago

Diane Yamada, MD Joseph Bolivar DeLee Professor

of Obstetrics and Gynecology

Chief, Section of

Gynecologic Oncology

University of Chicago

Katherine Kurnit, MD, MPH Assistant Professor of

Obstetrics and Gynecology

University of Chicago

KEYNOTE SPEAKERSMichael Bookman, MD Director, Gynecologic

Oncology Therapeutics

Kaiser Permanente

Matthew Powell, MD Professor

Obstetrics and Gynecology

Chief, Division of

Gynecologic Oncology

Washington University St. Louis

CONFERENCE FACULTY

Amina Ahmed, MD

Director, Cancer Service Line

Associate Professor

Department of OBGYN, Division

Gynecologic Oncology

Rush University Medical Center

Raanan Alter, MD

Gynecologic Oncology Fellow

University of Chicago

Emma Barber, MD, MS

Assistant Professor of

Obstetrics and Gynecology

(Gynecologic Oncology)

Northwestern University

Amanda Nickles Fader, MD

Vice Chair of Gynecologic

Surgical Operations

Associate Professor of

Gynecology and Obstetrics

Johns Hopkins Health System

Yasmin Hasan, MD

Associate Professor

Director of Gynecological

Brachytherapy

Residency Program Director

Department of Radiation and

Cellular Oncology at UCMC

Josephine Kim, MD

Assistant Professor

Department of Obstetrics

and Gynecology

University of Chicago

Ricardo Lastra, MD

Associate Professor of

Pathology

University of Chicago

Nita Lee, MD, MPH

Associate Professor of

Obstetrics and Gynecology

University of Chicago

Ernst Lengyel, MD, PhD

Arthur L. and Lee G Herbst

Professor of Obstetrics

and Gynecology

Chair, Department of

Obstetrics and Gynecology

University of Chicago

Daniela Matei, MD

Diana, Princess of Wales

Professor of Cancer Research

Professor of Medicine

(Hematology and Oncology)

And Obstetrics and Gynecology

(Gynecologic Oncology)

Northwestern University

Kathryn Mills, MD

Assistant Professor

Department of

Obstetrics & Gynecology

University of Chicago

John Moroney, MD

Associate Professor of

Obstetrics and Gynecology

University of Chicago

Kunle Odunsi, MD, PhD

Professor of Obstetrics

and Gynecology

BSD Dean for Oncology

Director of the University of

Chicago Comprehensive

Cancer Center

Blase Polite, MD

Professor of Medicine

University of Chicago

William Small, MD

Professor

Department Chairperson,

Radiation Oncology

Loyola University

Christina Son, MD

Assistant Professor

Department of Radiation and

Cellular Oncology

University of Chicago

Lydia Usha, MD

Professor of Medicine

Hematology, Oncology,

And Cell Therapy

Rush University Cancer Center

Tilley Jenkins Vogel, MD

Clinical Assistant Professor

NorthShore University

HealthSystem

University of Chicago

cme.uchicago.edu/GynOncUpdates2021

Page 4: C HICAGO GYN ONCOLOGY UPDATES

FRIDAY, MAY 14, 2021

8:00 am Introduction of Diane Yamada,

SGO President

Ernst Lengyel, MD, PhD

8:05 am WELCOME

Diane Yamada, MD

Kunle Odunsi, MD, PhD

FIRST HALF MODERATORS:

Katherine Kurnit, MD, MPH &

Josephine Kim, MD

OVARIAN CANCER

8:10 am Tumor Board Presentation

Raanan Alter, MD

Ricardo Lastra, MD

8:25 am Emerging Landscape in Front-

line Therapy of Ovarian Cancer

Michael Bookman, MD

8:50 am SGO Abstract Review:

Ovarian Cancer

Kathryn Mills, MD

9:10 am Q&A

WHIRLWIND TOUR OF IITs

IN THE CITY – PART A

9:20 am Metformin for Ovarian Cancer

Diane Yamada, MD

9:25 am Surgery for Older Women

with Ovarian Cancer

Amina Ahmed, MD

9:30 am Folate Repletion and

PARPi Therapy

Lydia Usha, MD

9:35 am Guadecitabine/Pembro

for Ovarian Cancer

Daniela Matei, MD

9:40 am NETWORKING

SECOND HALF MODERATORS:

John Moroney, MD & Yasmin Hasan, MD

ENDOMETRIAL CANCER

10:10 am Changing Landscape in

Therapy of Non-metastatic

Endometrial Cancer

Matthew Powell, MD

10:35 am SGO Abstract Review:

Endometrial Cancer

Tilley Jenkins Vogel, MD

WHIRLWIND TOUR OF IITs

IN THE CITY – PART B

10:45 am Exercise and Physical Activity

Interventions in Ovarian and

Endometrial Cancer

Nita Lee, MD, MPH

10:50 am Neoadjuvant Palbo/Letrozole

in Endometrial Cancer

Emma Barber, MD, MS

10:55 am Hypofractionation for

Cervical Cancer

Christina Son, MD

11:00 am Overcoming Barriers to Trial

Accrual for Underserved

Blase Polite, MD

CERVICAL CANCER/RARE TUMORS

11:10 am SGO Abstract Review:

Cervical Cancer

William Small, MD

11:30 am SGO Abstract Review:

Rare GYN Tumors

Amanda Nickles Fader, MD

11:50 am Q&A

12:00 pm NETWORKING

AGENDA

cme.uchicago.edu/GynOncUpdates2021

Page 5: C HICAGO GYN ONCOLOGY UPDATES

REGISTRATION FEE

PHYSICIANS o $50

OTHER HEALTHCARE o $30 PROFESSIONALS

RESIDENTS AND o $30 FELLOWS

INDUSTRY o $50

PATIENT REGISTRATION: COMPLIMENTARY - Reach out to [email protected]

HOW TO REGISTER ONLINE – (credit card payment only)

cme.uchicago.edu/GynOncUpdates2021

CANCELLATION POLICY If you cancel your participation in this conference, your registration fee less a 50% administrative fee will be refunded when written notification is received by April 14, 2021. No refunds will be made after April 14, 2021.

ADDITIONAL INFORMATION For information regarding course, contact [email protected].

REGISTRATION

cme.uchicago.edu/GynOncUpdates2021

DISCLOSURE DECLARATIONSAs a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks

everyone who is in a position to control the content of an education activity to disclose all relevant

financial relationships with any commercial interest. This includes any entity producing, marketing,

re-selling, or distributing health care goods or services consumed by or used on patients.

The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring

within the past 12 months, including financial relationships of a spouse or life partner that could create a

conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior

to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify

investigational products or off-label uses of products regulated by the US Food and Drug Administration,

at first mention and where appropriate in the content.

Page 6: C HICAGO GYN ONCOLOGY UPDATES

Th

e U

niv

ers

ity o

f C

hic

ag

oC

en

ter

for

Co

nti

nu

ing

Me

dic

al E

du

ca

tio

n5

84

1 S

. M

ary

lan

d A

ve

., M

C 1

137

Ch

ica

go

, IL

60

63

7

Fo

llo

w u

s o

n T

wit

ter:

@U

Ch

ica

go

CM

E

FR

IDA

Y,

MA

Y 1

4,

20

21

INA

UG

UR

AL

ME

ET

ING

: V

IRT

UA

L F

OR

MA

T